Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative Randomized Clinical Study on Covid-19 Positive Hospitalized Patients Supplemented With NASAFYTOL

NCT04844658 is registered in ClinicalTrials.gov with Tilman S.A. as lead sponsor.

NCT NCT04844658
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04844658 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative Randomized Clinical Study on Covid-19 Positive Hospitalized Patients Supplemented With NASAFYTOL
Lead sponsor
Tilman S.A.
Phase
Not applicable
Overall status
Completed
Start date
February 17, 2021
Completion date
March 31, 2022
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection